Online inquiry

IVTScrip™ mRNA-Human ANXA8, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21566MR)

This product GTTS-WK21566MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANXA8 protein. This product can be used in Basal cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001040084.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 653145
UniProt ID P13928
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANXA8, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21566MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27418MR IVTScrip™ mRNA-Human ARHGEF38, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF38
GTTS-WK3590MR IVTScrip™ mRNA-Human FBLN5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA FBLN5
GTTS-WK16760MR IVTScrip™ mRNA-Human ANXA2R, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANXA2R
GTTS-WK17027MR IVTScrip™ mRNA-Human ANKRD45, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD45
GTTS-WK25953MR IVTScrip™ mRNA-Human ARMC2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARMC2
GTTS-WK21811MR IVTScrip™ mRNA-Human ASGR2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASGR2
GTTS-WK16768MR IVTScrip™ mRNA-Human AOAH, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AOAH
GTTS-WK10691MR IVTScrip™ mRNA-Human ADAM17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM17
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →